Oxygen Biotherapeutics, Inc. And Virginia Commonwealth University to Create the Purple Heart Injury Laboratories in Cooperative Research Effort to Treat Battlefield Injuries
COSTA MESA, Calif.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) and Virginia Commonwealth University (VCU) today announced that they have signed a memorandum of understanding (MOU) to establish a federal defense appropriation-funded joint venture focusing on developing new treatments for military battlefield injuries.